vs
Ametek（AME）与NATIONAL RESEARCH CORP（NRC）财务数据对比。点击上方公司名可切换其他公司
Ametek的季度营收约是NATIONAL RESEARCH CORP的56.8倍（$2.0B vs $35.2M）。Ametek净利率更高（19.9% vs 5.1%，领先14.8%）。Ametek同比增速更快（13.4% vs -4.6%）。Ametek自由现金流更多（$527.3M vs $6.1M）。过去两年Ametek的营收复合增速更高（7.3% vs -0.2%）
AMETEK Inc.是美国跨国综合企业，为全球知名的电子仪器及机电设备设计商与制造商，总部位于美国，在全球范围内设有超过150个运营站点，业务覆盖多个国家和地区，为各行业客户提供高性能的相关产品及配套解决方案。
NRC Health（原国家研究公司）是一家美国医疗健康企业，1981年成立，总部位于内布拉斯加州林肯市。公司主要在美加两国提供医疗健康相关产品及订阅式解决方案，深耕区域医疗健康服务领域。
AME vs NRC — 直观对比
营收规模更大
AME
是对方的56.8倍
$35.2M
营收增速更快
AME
高出18.1%
-4.6%
净利率更高
AME
高出14.8%
5.1%
自由现金流更多
AME
多$521.2M
$6.1M
两年增速更快
AME
近两年复合增速
-0.2%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $2.0B | $35.2M |
| 净利润 | $398.6M | $1.8M |
| 毛利率 | 36.0% | — |
| 营业利润率 | 25.3% | 13.3% |
| 净利率 | 19.9% | 5.1% |
| 营收同比 | 13.4% | -4.6% |
| 净利润同比 | 2.9% | -72.6% |
| 每股收益（稀释后） | $1.73 | $49.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMENRC
| Q4 25 | $2.0B | $35.2M | ||
| Q3 25 | $1.9B | $34.6M | ||
| Q2 25 | $1.8B | $34.0M | ||
| Q1 25 | $1.7B | $33.6M | ||
| Q4 24 | $1.8B | $36.9M | ||
| Q3 24 | $1.7B | $35.8M | ||
| Q2 24 | $1.7B | $35.0M | ||
| Q1 24 | $1.7B | $35.3M |
净利润AMENRC
| Q4 25 | $398.6M | $1.8M | ||
| Q3 25 | $371.4M | $4.1M | ||
| Q2 25 | $358.4M | $-106.0K | ||
| Q1 25 | $351.8M | $5.8M | ||
| Q4 24 | $387.3M | $6.6M | ||
| Q3 24 | $340.2M | $5.7M | ||
| Q2 24 | $337.7M | $6.2M | ||
| Q1 24 | $310.9M | $6.4M |
毛利率AMENRC
| Q4 25 | 36.0% | — | ||
| Q3 25 | 36.3% | — | ||
| Q2 25 | 35.8% | — | ||
| Q1 25 | 36.1% | — | ||
| Q4 24 | 36.6% | — | ||
| Q3 24 | 36.0% | — | ||
| Q2 24 | 36.0% | — | ||
| Q1 24 | 34.1% | — |
营业利润率AMENRC
| Q4 25 | 25.3% | 13.3% | ||
| Q3 25 | 25.8% | 22.4% | ||
| Q2 25 | 26.0% | 4.7% | ||
| Q1 25 | 26.3% | 25.6% | ||
| Q4 24 | 26.6% | 26.0% | ||
| Q3 24 | 26.1% | 22.3% | ||
| Q2 24 | 25.8% | 25.3% | ||
| Q1 24 | 24.0% | 24.8% |
净利率AMENRC
| Q4 25 | 19.9% | 5.1% | ||
| Q3 25 | 19.6% | 11.9% | ||
| Q2 25 | 20.2% | -0.3% | ||
| Q1 25 | 20.3% | 17.2% | ||
| Q4 24 | 22.0% | 17.8% | ||
| Q3 24 | 19.9% | 15.9% | ||
| Q2 24 | 19.5% | 17.6% | ||
| Q1 24 | 17.9% | 18.0% |
每股收益（稀释后）AMENRC
| Q4 25 | $1.73 | $49.58 | ||
| Q3 25 | $1.60 | $0.18 | ||
| Q2 25 | $1.55 | $-0.01 | ||
| Q1 25 | $1.52 | $0.25 | ||
| Q4 24 | $1.67 | $0.27 | ||
| Q3 24 | $1.47 | $0.24 | ||
| Q2 24 | $1.45 | $0.26 | ||
| Q1 24 | $1.34 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $458.0M | $4.1M |
| 总债务越低越好 | $2.3B | — |
| 股东权益账面价值 | $10.6B | $14.0M |
| 总资产 | $16.1B | $134.9M |
| 负债/权益比越低杠杆越低 | 0.21× | — |
8季度趋势，按日历期对齐
现金及短期投资AMENRC
| Q4 25 | $458.0M | $4.1M | ||
| Q3 25 | $439.2M | $2.2M | ||
| Q2 25 | $619.7M | $5.3M | ||
| Q1 25 | $399.0M | $2.5M | ||
| Q4 24 | $374.0M | $4.2M | ||
| Q3 24 | $396.3M | $3.5M | ||
| Q2 24 | $396.6M | $485.0K | ||
| Q1 24 | $373.8M | $1.7M |
总债务AMENRC
| Q4 25 | $2.3B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | — | $48.7M | ||
| Q2 24 | — | $33.3M | ||
| Q1 24 | — | $35.2M |
股东权益AMENRC
| Q4 25 | $10.6B | $14.0M | ||
| Q3 25 | $10.5B | $14.3M | ||
| Q2 25 | $10.4B | $21.3M | ||
| Q1 25 | $10.0B | $29.7M | ||
| Q4 24 | $9.7B | $31.3M | ||
| Q3 24 | $9.6B | $34.6M | ||
| Q2 24 | $9.3B | $40.2M | ||
| Q1 24 | $9.0B | $36.9M |
总资产AMENRC
| Q4 25 | $16.1B | $134.9M | ||
| Q3 25 | $16.2B | $135.7M | ||
| Q2 25 | $15.3B | $141.4M | ||
| Q1 25 | $14.9B | $135.2M | ||
| Q4 24 | $14.6B | $132.5M | ||
| Q3 24 | $14.8B | $131.8M | ||
| Q2 24 | $14.8B | $119.1M | ||
| Q1 24 | $14.9B | $120.9M |
负债/权益比AMENRC
| Q4 25 | 0.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.22× | — | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | — | 0.95× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $584.3M | $7.2M |
| 自由现金流经营现金流 - 资本支出 | $527.3M | $6.1M |
| 自由现金流率自由现金流/营收 | 26.4% | 17.2% |
| 资本支出强度资本支出/营收 | 2.9% | 3.2% |
| 现金转化率经营现金流/净利润 | 1.47× | 3.99× |
| 过去12个月自由现金流最近4个季度 | $1.7B | $15.7M |
8季度趋势，按日历期对齐
经营现金流AMENRC
| Q4 25 | $584.3M | $7.2M | ||
| Q3 25 | $440.9M | $13.8M | ||
| Q2 25 | $359.1M | $-1.1M | ||
| Q1 25 | $417.5M | $6.6M | ||
| Q4 24 | $550.0M | $6.4M | ||
| Q3 24 | $487.2M | $9.4M | ||
| Q2 24 | $381.4M | $6.8M | ||
| Q1 24 | $410.2M | $12.0M |
自由现金流AMENRC
| Q4 25 | $527.3M | $6.1M | ||
| Q3 25 | $420.0M | $10.2M | ||
| Q2 25 | $329.8M | $-4.1M | ||
| Q1 25 | $394.5M | $3.7M | ||
| Q4 24 | $498.3M | $1.9M | ||
| Q3 24 | $460.9M | $7.8M | ||
| Q2 24 | $360.0M | $1.5M | ||
| Q1 24 | $382.6M | $7.9M |
自由现金流率AMENRC
| Q4 25 | 26.4% | 17.2% | ||
| Q3 25 | 22.2% | 29.4% | ||
| Q2 25 | 18.5% | -12.2% | ||
| Q1 25 | 22.8% | 10.9% | ||
| Q4 24 | 28.3% | 5.2% | ||
| Q3 24 | 27.0% | 21.8% | ||
| Q2 24 | 20.8% | 4.3% | ||
| Q1 24 | 22.0% | 22.4% |
资本支出强度AMENRC
| Q4 25 | 2.9% | 3.2% | ||
| Q3 25 | 1.1% | 10.4% | ||
| Q2 25 | 1.6% | 8.8% | ||
| Q1 25 | 1.3% | 8.9% | ||
| Q4 24 | 2.9% | 12.0% | ||
| Q3 24 | 1.5% | 4.5% | ||
| Q2 24 | 1.2% | 15.0% | ||
| Q1 24 | 1.6% | 11.7% |
现金转化率AMENRC
| Q4 25 | 1.47× | 3.99× | ||
| Q3 25 | 1.19× | 3.34× | ||
| Q2 25 | 1.00× | — | ||
| Q1 25 | 1.19× | 1.15× | ||
| Q4 24 | 1.42× | 0.97× | ||
| Q3 24 | 1.43× | 1.66× | ||
| Q2 24 | 1.13× | 1.10× | ||
| Q1 24 | 1.32× | 1.89× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AME
| Transferred At Point In Time | $1.1B | 54% |
| Electronic Instruments Group | $620.1M | 31% |
| Transferred Over Time | $294.6M | 15% |
NRC
暂无分部数据
